tiprankstipranks
Trending News
More News >
Radiopharm Theranostics Limited Sponsored ADR (RADX)
NASDAQ:RADX
US Market

Radiopharm Theranostics Limited Sponsored ADR (RADX) Income Statement

Compare
52 Followers

Radiopharm Theranostics Limited Sponsored ADR Income Statement

See RADX’s key income statement, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 22
Total Revenue
AU$ 3.63MAU$ 299.23KAU$ 8.83KAU$ 292.36K
Gross Profit
AU$ 39.28KAU$ 299.23KAU$ 8.83KAU$ 292.36K
Operating Expenses
AU$ 38.21MAU$ 36.92MAU$ 19.93MAU$ 34.80M
Depreciation and Amortization
AU$ 7.33KAU$ 3.13MAU$ 2.98MAU$ 3.30M
EBITDA
AU$ -38.17MAU$ -44.08MAU$ -17.96MAU$ -31.19M
Operating Income
AU$ -38.17MAU$ -36.62MAU$ -19.92MAU$ -34.51M
Other Income/Expenses
AU$ -65.30KAU$ -11.23MAU$ -10.38MAU$ -65.10K
Pretax Income
AU$ -38.24MAU$ -47.85MAU$ -30.29MAU$ -34.57M
Net Income
AU$ -38.34MAU$ -47.95MAU$ -30.34MAU$ -34.61M
Per Share Metrics
Basic EPS
AU$ -5.28AU$ -36.00AU$ -29.76AU$ -33.00
Diluted EPS
AU$ -5.28AU$ -36.00AU$ -29.76AU$ -33.00
Weighted Average Shares Outstanding
6.94M 1.29M 1.02M 1.02M
Weighted Average Shares Outstanding (Diluted)
6.94M 1.29M 1.02M 1.02M
Currency in AUD

Radiopharm Theranostics Limited Sponsored ADR Earnings and Revenue History